Prenetics Global (NASDAQ:PRE) reported quarterly losses of $(1.61) per share which missed the analyst consensus estimate of $(0.82) by 96.34 percent. This is a 265.91 percent decrease over losses of $(0.44) per share from the same period last year. The company reported quarterly sales of $35.954 million which missed the analyst consensus estimate of $37.849 million by 5.01 percent. This is a 334.49 percent increase over sales of $8.275 million the same period last year.